icecure-medical.com (ICCM) - Long-Term Debt to Capital Coefficient

ProSense's patented nitrogen cryoablation creates a significant technological barrier for competitors. The long-term debt-to-equity dynamics help track shifts in credit load, where 0.00 serves as the current parameter value. The innovativeness of IceCure Medical Ltd systems is valued by surgeons for its precision. However, implementing the method requires years of certification and approval from professional medical communities.

This metric is calculated as the ratio of long-term liabilities to equity, reacting slowly to operational changes. It measures the degree of financial leverage and the risk of insolvency in the event of declining revenues. For IceCure Medical Ltd (ICCM), the balance of borrowings is critical when financing the development of cryoablation systems and electronics disposal control. The historical long-term debt-to-equity level reflects the company's ability to invest in technological reliability without the risk of bankruptcy.